Loading...
CNC logo

Centene CorporationNYSE:CNC Stock Report

Market Cap US$16.3b
Share Price
US$33.26
My Fair Value
US$34
0.9% undervalued intrinsic discount
1Y-56.6%
7D15.3%
Portfolio Value
​
View

Centene Corporation

NYSE:CNC Stock Report

Market Cap: US$16.3b

Centene (CNC) Stock Overview

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. More details

CNC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 81.8% below our estimate of its fair value

Earnings are forecast to grow 19.26% per year

Trading at good value compared to peers and industry

Risk Analysis

Profit margins (1.3%) are lower than last year (2%)

Volatile share price over the past 3 months compared to the US market


CNC Community Fair Values

Create Narrative

See what 91 others think this stock is worth. Follow their fair value or set your own to get alerts.

CNC logo
Centene

Medicaid And Medicare Advantage Will Expand Health Care Access

Key Takeaways Medicaid business margin recovery and strong contract wins could enhance revenue growth and market share in government health programs. Improved Medicare Advantage outlook, alongside commercial segment growth, supports positive revenue and earnings prospects through operational efficiencies and increased membership.
View narrative
US$33.56
FV
0.9% undervalued intrinsic discount
7.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
39users have followed this narrative
5 days ago author updated this narrative
CNC logo
Centene

Medicare And Medicaid Expansion Will Unlock Long-Term Healthcare Potential

Key Takeaways Accelerated margin rebound and profitability are possible through strong execution, digital transformation, and advanced care management, surpassing current analyst expectations. Dominance in government health programs and effective policy advocacy ensure continued revenue growth, coverage expansion, and earnings stability as populations age and chronic disease rises.
View narrative
US$54.65
FV
39.1% undervalued intrinsic discount
10.57%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
5 days ago author updated this narrative
CNC logo
Centene

Rising Regulatory Pressure And Contracting Medicaid Will Squeeze Margins

Key Takeaways Intensifying regulatory scrutiny, demographic headwinds, and operational inefficiencies threaten Centene's profitability and margin stability in both Medicaid and Marketplace segments. Competitive pressures from technological disruption and dependence on government contracts raise risks of revenue attrition and long-term earnings volatility.
View narrative
US$24
FV
38.6% overvalued intrinsic discount
4.35%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
5 days ago author updated this narrative
View Stock Community

Centene Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Centene
Historical stock prices
Current Share PriceUS$33.26
52 Week HighUS$77.29
52 Week LowUS$25.08
Beta0.44
1 Month Change16.74%
3 Month Change-39.43%
1 Year Change-56.56%
3 Year Change-60.76%
5 Year Change-40.60%
Change since IPO2,220.46%

Recent News & Updates

Centene Corporation's (NYSE:CNC) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 12
Centene Corporation's (NYSE:CNC) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Centene: Enrollment Down, Costs Up, The Storm Is Just Beginning

Sep 10

Recent updates

Centene Corporation's (NYSE:CNC) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 12
Centene Corporation's (NYSE:CNC) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Centene: Enrollment Down, Costs Up, The Storm Is Just Beginning

Sep 10

Why Investors Shouldn't Be Surprised By Centene Corporation's (NYSE:CNC) 38% Share Price Plunge

Jul 03
Why Investors Shouldn't Be Surprised By Centene Corporation's (NYSE:CNC) 38% Share Price Plunge

Centene (NYSE:CNC) Is Doing The Right Things To Multiply Its Share Price

May 15
Centene (NYSE:CNC) Is Doing The Right Things To Multiply Its Share Price

Centene Corporation's (NYSE:CNC) Low P/E No Reason For Excitement

Apr 03
Centene Corporation's (NYSE:CNC) Low P/E No Reason For Excitement

Centene: A Leader In Government-Sponsored Insurance And Its Prospects

Mar 26

Centene Corporation Is Resilient And Will Thrive

Mar 18

Centene's (NYSE:CNC) Returns On Capital Not Reflecting Well On The Business

Jan 27
Centene's (NYSE:CNC) Returns On Capital Not Reflecting Well On The Business

Centene: Attractive Risk-Reward For A Growing Company At A Value Price

Jan 02

Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?

Dec 05
Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?

Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024

Oct 22

Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch

Oct 14
Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch

Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?

Sep 26
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?

Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy

Aug 20

Centene Corporation Still An Opportunity With An A-Grade Valuation

Mar 31

Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain

Jan 22

Centene: Overlooked Healthcare Giant

Nov 21

Centene: Solid Performance With Positive Outlook, But Limited Upside Potential

Oct 26

Decoding Centene: Why I Think It's Undervalued

Oct 10

Shareholder Returns

CNCUS HealthcareUS Market
7D15.3%4.0%1.6%
1Y-56.6%-24.2%18.5%

Return vs Industry: CNC underperformed the US Healthcare industry which returned -24.2% over the past year.

Return vs Market: CNC underperformed the US Market which returned 18.5% over the past year.

Price Volatility

Is CNC's price volatile compared to industry and market?
CNC volatility
CNC Average Weekly Movement13.4%
Healthcare Industry Average Movement6.7%
Market Average Movement6.4%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.0%

Stable Share Price: CNC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: CNC's weekly volatility has increased from 8% to 13% over the past year.

About the Company

FoundedEmployeesCEOWebsite
198460,500Sarah Londonwww.centene.com

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.

Centene Corporation Fundamentals Summary

How do Centene's earnings and revenue compare to its market cap?
CNC fundamental statistics
Market capUS$16.34b
Earnings (TTM)US$2.05b
Revenue (TTM)US$159.56b
8.0x
P/E Ratio
0.1x
P/S Ratio

Is CNC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNC income statement (TTM)
RevenueUS$159.56b
Cost of RevenueUS$139.32b
Gross ProfitUS$20.24b
Other ExpensesUS$18.19b
EarningsUS$2.05b

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)4.18
Gross Margin12.68%
Net Profit Margin1.29%
Debt/Equity Ratio63.9%

How did CNC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/15 16:44
End of Day Share Price 2025/09/12 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Centene Corporation is covered by 45 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Hua HaBaird
Ishan MajumdarBaptista Research